2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Implementation of a High-Resolution Liquid Chromatography–Mass Spectrometry Method in Quality Control Laboratories for Release and Stability Testing of a Commercial Antibody Product

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d3856553e134">Liquid chromatography-mass spectrometry (LC-MS) has been widely used throughout biotherapeutic development. However, its implementation in GMP-compliant commercial quality control (QC) laboratories remains a challenge. In this publication, we describe the covalidation and implementation of an automated, high-throughput, and GMP compliant subunit LC-MS method for monitoring antibody oxidation for commercial product release and stability testing. To our knowledge, this is the first report describing the implementation of a high-resolution LC-MS method in commercial QC laboratories for product release and stability testing in the biopharmaceutical industry. This work paves the road for implementing additional LC-MS methods to modernize testing in commercial QC with more targeted control of product quality. </p>

          Related collections

          Author and article information

          Journal
          Analytical Chemistry
          Anal. Chem.
          American Chemical Society (ACS)
          0003-2700
          1520-6882
          December 27 2019
          December 27 2019
          Affiliations
          [1 ]BioTherapeutics Analytical Development, Janssen Research & Development, LLC, 200 Great Valley Parkway, Malvern, Pennsylvania 19355, United States
          [2 ]Janssen Supply Chain One Lab, Janssen Biologics BV, Einsteinweg 101, 2333 CB Leiden, The Netherlands
          [3 ]BioTherapeutics Analytical Development, Janssen Biologics BV, Einsteinweg 101, 2333 CB Leiden, The Netherlands
          Article
          10.1021/acs.analchem.9b05036
          31869206
          7bc94897-6216-4879-b425-5c58375a3322
          © 2019
          History

          Comments

          Comment on this article